STOCKWATCH
·
Pharmaceuticals
Quarterly Result26 Nov 2025, 07:41 pm

Dipna Pharmachem Ltd Reports Q3 2025 Financial Results with 141.10% YoY Growth in Net Profit

AI Summary

Dipna Pharmachem Ltd, a leading player in the pharmaceutical trading sector, has reported its financial results for the quarter ended on 30th September 2025. The company has recorded a significant growth in its net profit, which stood at INR 141.10 Lakhs, marking a 141.10% YoY growth. The total income from operations was INR 9062.38 Lakhs, a 24.88% YoY growth. The company's profit before tax was INR 190.65 Lakhs, a 256.32% YoY growth. The company's assets and liabilities have also seen a significant increase, reflecting its growth and financial health.

Key Highlights

  • Net profit for the period from continuing operations stood at INR 141.10 Lakhs, marking a 141.10% YoY growth.
  • Total income from operations was INR 9062.38 Lakhs, a 24.88% YoY growth.
  • Profit before tax was INR 190.65 Lakhs, a 256.32% YoY growth.
  • The company's assets and liabilities have seen a significant increase.
  • The financial results have been reviewed by the Audit Committee and approved by the Board of Directors.
DPL
Pharmaceuticals
Dipna Pharmachem Ltd

Price Impact